Recombinant Mouse FGFR4 Fc Chimera Protein, CF

Catalog # Availability Size / Price Qty
2265-FR-050
R&D Systems Recombinant Proteins and Enzymes
1 Image
Product Details
Citations (1)
FAQs
Supplemental Products
Reviews

Recombinant Mouse FGFR4 Fc Chimera Protein, CF Summary

Product Specifications

Purity
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its ability to inhibit FGF acidic-dependent proliferation of NR6R‑3T3 mouse fibroblast cells. The ED50 for this effect is typically 7-35 ng/mL.
Source
Mouse myeloma cell line, NS0-derived mouse FGF R4 protein
Mouse FGF R4
(Leu19-Asp366)
Accession # Q03142
IEGRMDP Mouse IgG2A
(Glu98-Lys330)
N-terminus C-terminus
Accession #
N-terminal Sequence
Analysis
Leu19
Structure / Form
Disulfide-linked homodimer
Predicted Molecular Mass
66 kDa (monomer)
SDS-PAGE
90-100 kDa, reducing conditions

Product Datasheets

You must select a language.

x

2265-FR

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

2265-FR

Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution Reconstitute at 100 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: FGFR4

Fibroblast growth factor receptor 4 (FGF R4), also known as CD334, is a 110 kDa glycosylated transmembrane receptor tyrosine kinase (1). Mature mouse FGF R4 consists of a 350 amino acid (aa) extracellular domain (ECD) with three Ig-like domains, a 21 aa transmembrane segment, and a 412 aa cytoplasmic domain that contains the tyrosine kinase domain (2). Within the ECD, mouse FGF R4 shares 90% and 96% aa sequence identity with human and rat FGF R4, respectively. Alternate splicing generates additional isoforms that have deletions within or C-terminal to the kinase domain (3, 4). FGF R4 is widely expressed during embryonic development and in adult liver, kidney, and lung (2, 5, 6, 7). It binds FGF acidic, FGF basic, FGF-8, -15, and -19 (6, 8‑12). FGF R4 associates with beta-Klotho and sulfated glycosaminoglycans, and these interactions increase the affinity of FGF R4 for its ligands as well as its signaling capacity (7, 9, 12). FGF-19 induced signaling through FGF R4 is important for the regulation of bile acid synthesis and lipid and glucose homeostasis (10, 13). FGF R4 supports glucose tolerance and insulin sensitivity and protects against hyperlipidemia (13). It is down‑regulated in the liver during fasting and is up‑regulated by insulin (10). It can exert either proliferative or apoptotic effects on hepatocytes (7, 11). FGF R4 signaling is additionally required for skeletal muscle development in limbs (4, 6). FGF R4 interacts in cis with cell surface MMP-14, leading to down‑regulation of both proteins (14). In contrast, the Arg388 variant of FGF R4, which is associated with tumor progression in human cancer, is activated and stabilized by MMP-14 (14, 15).

References
  1. Haugsten, E.M. et al. (2010) Mol. Cancer Res. 8:1439.
  2. Stark, K.L. et al. (1991) Development 113:641.
  3. van Heumen, W.R.A. et al. (1999) IUBMB Life 48:73.
  4. Kwiatkowski, B.A. et al. (2008) J. Cell Physiol. 215:803.
  5. Korhonen, J. et al. (1992) Int. J. Dev. Biol. 36:323.
  6. Marics, I. et al. (2002) Development 129:4559.
  7. Luo, Y. et al. (2010) J. Biol. Chem. 285:30069.
  8. Partanen, J. et al. (1991) EMBO J. 10:1347.
  9. Saxena, K. et al. (2010) J. Biol. Chem. 285:26628.
  10. Shin, D.J. and T.F. Osborne (2009) J. Biol. Chem. 284:11110.
  11. Wu, X. et al. (2010) J. Biol. Chem. 285:5165.
  12. Nakamura, M. et al. (2011) J. Biol. Chem. 286:26418.
  13. Huang, X. et al. (2007) Diabetes 56:2501.
  14. Sugiyama, N. et al. (2010) Proc. Natl. Acad. Sci. 107:15786.
  15. Bange, J. et al. (2002) Cancer Res. 62:840.
Long Name
Fibroblast Growth Factor Receptor 4
Entrez Gene IDs
2264 (Human); 14186 (Mouse)
Alternate Names
CD334 antigen; CD334; EC 2.7.10; EC 2.7.10.1; FGF R4; FGFR4; FGFR-4; fibroblast growth factor receptor 4; JTK2hydroxyaryl-protein kinase; MGC20292; protein-tyrosine kinase; TKF; tyrosine kinase related to fibroblast growth factor receptor; tyrosylprotein kinase

Citation for Recombinant Mouse FGFR4 Fc Chimera Protein, CF

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

1 Citation: Showing 1 - 1

  1. Pre-clinical development of U3-1784, a novel FGFR4 antibody against cancer, and avoidance of its on-target toxicity
    Authors: R Bartz, K Fukuchi, T Ohtsuka, T Lange, K Gruner, I Watanabe, S Hayashi, Y Oda, R Kawaida, H Komori, Y Kashimoto, P Wirtz, JA Mayer, M Redondo-Mü, S Saito, M Takahashi, H Hanzawa, E Imai, A Martinez, M Hanai, D Häussinger, RW Chapman, T Agatsuma, J Bange, R Abraham
    Mol. Cancer Ther., 2019-07-26;0(0):.
    Species: Mouse
    Sample Types: Recombinant Protein
    Applications: ELISA Capture

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs
Loading...

Reviews for Recombinant Mouse FGFR4 Fc Chimera Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Mouse FGFR4 Fc Chimera Protein, CF and earn rewards!

Have you used Recombinant Mouse FGFR4 Fc Chimera Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review